Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 30 (4), 653-659
- https://doi.org/10.1016/s0168-8278(99)80196-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Circulating HCV‐RNA, HCV genotype, and liver histology in asymptomatic individuals reactive for anti‐HCV antibody and their follow‐up studyLiver International, 1996
- Can interferon prevent hepatocellular carcinoma in hepatitis C virus- induced cirrhosis?Gastroenterology, 1996
- Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?Hepatology, 1996
- Serial hemodynamic measurements in well-differentiated hepatocellular carcinomasHepatology, 1995
- Factors predictive of response to interferon-α therapy in hepatitis C virus infectionHepatology, 1994
- Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trialHepatology, 1993
- Biological activities of recombinant murine interferons alpha 1 and alpha 4: large difference in antiproliferative effectAntiviral Research, 1992
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991
- Deletions of Interferon Genes in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1990
- Interferon: a cytotoxic T lymphocyte differentiation signalEuropean Journal of Immunology, 1986